Table 2.
The anthropometric characteristics, pancreatic abnormalities, lifestyle-related diseases, glucose and lipid profiles, and hepatic abnormalities for 919 participants with tertile stratification according to the brightness score of pancreas.
| Low brightness | Medium brightness | High brightness | P-value | ||
| (n = 306) | (n = 306) | (n = 307) | Low versus medium | Low versus high | |
| Age, yrs | 56.0 ± 14.3 | 59.8 ± 13.0 | 62.6 ± 11.1 | .001 | <.001 |
| Sex, males/females (n) | 128/178 | 168/138 | 203/104 | <.001 | |
| Weight, kg | 54.8 ± 10.0 | 63.0 ± 12.2 | 69.1 ± 12.6 | <.001 | <.001 |
| BMI | 21.0 ± 2.7 | 23.8 ± 3.4 | 25.7 ± 3.3 | <.001 | <.001 |
| Waist circumference, cm | 77.5 ± 7.8 | 85.7 ± 8.5 | 91.6 ± 8.0 | <.001 | <.001 |
| Pancreatic abnormalities | |||||
| Amylase, U/L | 91.3 ± 31.0 | 80.4 ± 26.4 | 74.9 ± 23.2 | .001 | <.001 |
| Lipase, U/L | 35.4 ± 13.6 | 34.8 ± 13.1 | 33.2 ± 19.3 | .931 | .431 |
| Brightness score of pancreas | 78.9 ± 11.5 | 108.7 ± 7.7 | 137.3 ± 11.0 | <.001 | <.001 |
| Pancreatic cyst (%) | 6.3 | 4.1 | 5.5 | .528 | |
| Life style-related diseases | |||||
| Hypertention (%) | 6.2 | 11.4 | 11.7 | .035 | |
| Diabetes mellitus (%) | 4.2 | 8.8 | 17.3 | <.001 | |
| Dyslipidemia (%) | 21.2 | 39.5 | 51.8 | <.001 | |
| Metabolic syndrome (%) | 6.5 | 29.1 | 54.7 | <.001 | |
| Frequency of alcohol intake 0/1/2 | 160/98/48 | 148/82/76 | 150/76/81 | .012 | |
| Amount of alcohol intake 0/1/2 | 233/50/17 | 211/63/28 | 205/53/44 | .003 | |
| Gallbladder stones (%) | 4.6 | 8.2 | 10.1 | .033 | |
| Glucose metabolism and lipid profiles | |||||
| FPG, mg/dL | 97.4 ± 10.9 | 103.6 ± 18.8 | 106.8 ± 17.8 | <.001 | <.001 |
| HbA1c, % | 5.6 ± 0.4 | 5.8 ± 0.5 | 5.9 ± 0.6 | .025 | <.001 |
| HDL-C, mg/dL | 70.1 ± 17.1 | 61.6 ± 16.3 | 56.9 ± 13.1 | <.001 | <.001 |
| LDL-C, mg/dL | 114.6 ± 28.7 | 121.8 ± 28.9 | 124.3 ± 28.5 | .006 | <.001 |
| TG, mg/dL | 80.6 ± 42.6 | 114.1 ± 72.5 | 132.4 ± 139.1 | <.001 | <.001 |
| Triglyceride and glucose (TyG) index | 8.2 ± 0.5 | 8.5 ± 0.5 | 8.7 ± 0.6 | <.001 | <.001 |
| Hepatic abnormalities | |||||
| steatosis grade by US 0/1/2/3 | 278/10/11/7 | 211/26/24/45 | 116/35/41/115 | <.001 | |
| Platelet, ×1010/L | 23.4 ± 5.3 | 23.8 ± 6.1 | 23.2 ± 5.4 | 0.660 | .896 |
| Albumin, g/dL | 4.4 ± 0.3 | 4.4 ± 0.3 | 4.4 ± 0.3 | 1.000 | .208 |
| AST, U/L | 22.5 ± 7.6 | 24.0 ± 9.3 | 25.7 ± 10.4 | .138 | <.001 |
| ALT, U/L | 18.5 ± 10.4 | 23.4 ± 15.7 | 27.6 ± 18.3 | <.001 | <.001 |
| ALP, U/L | 198.7 ± 61.9 | 209.7 ± 66.2 | 221.3 ± 66.1 | 0.342 | 0.002 |
| γ-GT, U/L | 25.9 ± 30.7 | 37.9 ± 52.8 | 42.2 ± 36.3 | <.001 | <.001 |
| Fib-4 index | 1.41 ± 0.72 | 1.44 ± 0.76 | 1.50 ± 0.68 | .017 | <.001 |
| Hepatic steatosis index (HSI) | 28.7 ± 3.7 | 32.3 ± 5.0 | 35.0 ± 5.4 | <.001 | <.001 |
| Others | |||||
| CRP, mg/dL | 0.08 ± 0.42 | 0.12 ± 0.31 | 0.10 ± 0.16 | 1.000 | 1.000 |